tyb
'Pension payouts to decrease' deleted from finance minister's advisory council brief
TOKYO – The Ministry of Finance deleted parts of an opinion brief drafted by an advisory council to the finance minister on fiscal administration and other matters – such as that pension payouts for future generations are expected to decrease – it has emerged.
The deletions were disclosed by a source involved in the case. The Mainichi Shimbun also obtained a copy of the draft, which had not been made public, that the Finance Ministry presented to members of the advisory council.
This comes on the heels of Finance Minister and Minister of State for Financial Services (FSA) Taro Aso's refusal on June 11 to accept a report drawn up by a working group under an advisory panel to the FSA. The panel had concluded that on top of their pensions, the average elderly couple would need 20 million yen to fund a 30-year retirement. Aso subsequently cited the "misunderstanding and concern" toward the pension system that such a report would cause as his reason for not accepting it.
"The parts (in the advisory council's draft brief) were probably erased out of consideration for the government," one committee member said.
The original draft of the opinion brief points out that the macroeconomic slide formula, which automatically suppresses pension benefits based on decreases in the working-age population, is not sufficiently working. It explicitly states, "The levels of basic pension payouts are expected to be lower for future generations than were projected at the time pension reforms were made in 2004."
The draft opinion also touches upon the changing social environment with increasing numbers of senior citizens who work. It states that in deliberating the pension system going forward, attention must be given not only to appropriate redistribution between various generations, and the burden that could fall on state coffers, but also the importance of urging the public to make the effort to help themselves. "Making efforts to help oneself" is believed to mean such things as continuing to work into one's later years to create income.
Such items were eliminated from the opinion brief that was compiled by the advisory council June 19.
Asked why the deletions took place, the Finance Ministry told the Mainichi Shimbun, "We will not comment on our reasons for each and every thing."
https://mainichi.jp/english/articles/20190620/p2a/00m/0na/004000c
Athenex Bio is bought by Perceptive Advisors LLC Mgmt $2.33m-June 17
Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies.
The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics.
The Company offers Oraxol, an oral formulation of paclitaxel; Orateacan, an oral formulation of Irinotecan; Oradoxel, an oral formulation of Docetaxel,
and an oral formulation of Topotecan for the treatment of various types of cancers. Its Src Kinase Inhibitors include KX-01 (KX2-391) and KX-02 (KX2-361) oncology drug candidates.
The Company's Symptom Therapeutics include CQ-01, which is used for the treatment of burn pruritus and scars; CQ-R1, which is used for the treatment of an irradiation-induced dermatitis,
and an intranasal Granisetron used for the treatment of chemotherapy-induced nausea/vomiting.
Number of employees : 477 people.
https://www.marketscreener.com/ATHENEX-INC-35806862/company/
https://www.secform4.com/insider-trading/1300699.htm
Cap#2
Athenex Provides an Update on its Chongqing API Plant
(GLOBE NEWSWIRE) – Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that its active pharmaceutical ingredient (API) plant in Chongqing, China has voluntarily suspended production activities. The voluntary temporary suspension occurred last month, and the Company expects to have a resolution by the end of the third quarter of 2019, subject to inspection and evaluation by the Department of Emergency Management of Chongqing. This voluntary action came after tragic accidents at other chemical plants in March and April 2019 in certain provinces of China that led to industry-wide plant inspections focused on production safety. Athenex believes that this self-imposed action demonstrates the Company’s good faith in working with the Department of Emergency Management of Chongqing and that the Company takes work safety very seriously.
The Company has communicated its decision to voluntarily suspend production to its customers. The Company plans to continue selling existing API inventories through at least the third quarter of this year. The Company believes that it has sufficient API inventory for all ongoing and near term planned clinical studies, and for its registration activities for late-stage clinical products. In addition, the Company is in the process of working with its secondary suppliers and securing additional suppliers subject to its needs, as part of normal course supply chain activities. The build-out of the new API plant in Chongqing is near completion and the plant is expected to commence operations in the first half of 2020. Athenex re-affirms its product sales guidance of a 25% to 30% increase in 2019 from the product sales revenue of $56.4 million reported in 2018.
The decision to voluntarily suspend production activities at the API plant was made to ease concerns from the Department of Emergency Management of Chongqing, which has been evaluating the safety of all chemical and other plants in the region after the recent tragic accidents at other plants in the region. The Company believes the API plant has been in compliance from a safety and regulatory perspective. The Company will continue to work closely with the department and aims to conclude the inspection as soon as practicable.
https://www.marketscreener.com/ATHENEX-INC-35806862/news/Athenex-Provides-an-Update-on-its-Chongqing-API-Plant-28715676/
the 28 post shit poster can't seem to pay attention.
you obviously don't pay much attention to habbenings. also were unaware of the full situation. LG came through when he needed to, whatever the circumstances are/were leading up to that, those can be dealt with at a later date. Or would you rather not have justice k confirmed?
eat shit glow boy
It's not really going crazy, when you see a parabolic spike that does not flatten out then you can lend some credence to a panic buying situation. Far from it now.
feel you though.
o7